DaVita Inc.
General ticker "DVA" information:
- Sector: Health Care
- Industry: Medical - Care Facilities
- Capitalization: $10.2B (TTM average)
DaVita Inc. follows the US Stock Market performance with the rate: 38.5%.
Estimated limits based on current volatility of 1.2%: low 177.56$, high 182.61$
Factors to consider:
- Company included in S&P500 list
- Total employees count: 78000 (+2.6%) as of 2025
- Top business risk factors: Government regulation, Labor/talent shortage/retention, Market competition, Acquisition/divestiture risks, Geopolitical risks
- Current price 19.3% above estimated high
- Earnings for 6 months up through Q2 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [104.88$, 154.22$]
- 2026-12-31 to 2027-12-31 estimated range: [114.24$, 165.89$]
Financial Metrics affecting the DVA estimates:
- Negative: with PPE of 10.5 at the end of fiscal year the price was high
- Positive: 11.29 < Operating profit margin, % of 14.94
- Positive: 15.29 < Operating cash flow per share per price, % of 19.16
- Negative: 4.56 < Interest expense per share per price, % of 5.89
- Positive: -7.11 < Investing cash flow per share per price, % of -6.65
- Negative: Shareholder equity ratio, % of -3.72 <= 7.04
- Negative: Industry operating cash flow per share per price (median), % of 4.90 <= 5.56
- Negative: Return on assets ratio (scaled to [-100,100]) of 5.69 <= 7.19
- Positive: Inventory ratio change, % of 0.13 <= 0.41
Short-term DVA quotes
Relationship graph
Long-term DVA plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $12,168.01MM | $12,951.20MM | $13,676.07MM |
| Operating Expenses | $10,565.23MM | $10,860.72MM | $11,632.45MM |
| Operating Income | $1,602.78MM | $2,090.48MM | $2,043.62MM |
| Non-Operating Income | $-425.69MM | $-560.09MM | $-696.79MM |
| Interest Expense | $398.55MM | $470.47MM | $579.93MM |
| Income(Loss) | $1,177.09MM | $1,530.39MM | $1,346.82MM |
| Taxes | $220.12MM | $279.66MM | $293.11MM |
| Other Income(Loss) | $0.00MM | $0.00MM | $25.00MM |
| Net Income(Loss)* | $691.53MM | $936.34MM | $746.80MM |
| Stockholders Equity | $1,056.10MM | $121.12MM | $-651.08MM |
| Inventory | $143.10MM | $134.56MM | $160.63MM |
| Assets | $16,893.58MM | $17,285.27MM | $17,480.10MM |
| Operating Cash Flow | $2,059.03MM | $2,022.04MM | $1,886.50MM |
| Capital expenditure | $567.99MM | $555.44MM | $575.86MM |
| Investing Cash Flow | $-771.80MM | $-771.43MM | $-654.95MM |
| Financing Cash Flow | $-1,170.49MM | $-816.94MM | $-1,374.78MM |
| Earnings Per Share** | $7.62 | $11.02 | $8.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.